{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:04:26Z","timestamp":1775174666834,"version":"3.50.1"},"reference-count":40,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007029","name":"Higher Education and Science Committee MoESCS RA","doi-asserted-by":"publisher","award":["21AG-1F021"],"award-info":[{"award-number":["21AG-1F021"]}],"id":[{"id":"10.13039\/501100007029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Massively parallel sequencing technologies have advanced chronic lymphocytic leukemia (CLL) diagnostics and precision oncology. Illumina platforms, while offering robust performance, require substantial infrastructure investment and a large number of samples for cost-efficiency. Conversely, third-generation long-read nanopore sequencing from Oxford Nanopore Technologies (ONT) can significantly reduce sequencing costs, making it a valuable tool in resource-limited settings. However, nanopore sequencing faces challenges with lower accuracy and throughput than Illumina platforms, necessitating additional computational strategies. In this paper, we demonstrate that integrating publicly available short-read data with in-house generated ONT data, along with the application of machine learning approaches, enables the characterization of the CLL transcriptome landscape, the identification of clinically relevant molecular subtypes, and the assignment of these subtypes to nanopore-sequenced samples. Methods: Public Illumina RNA sequencing data for 608 CLL samples were obtained from the CLL-Map Portal. CLL transcriptome analysis, gene module identification, and transcriptomic subtype classification were performed using the oposSOM R package for high-dimensional data visualization with self-organizing maps. Eight CLL patients were recruited from the Hematology Center After Prof. R. Yeolyan (Yerevan, Armenia). Sequencing libraries were prepared from blood total RNA using the PCR-cDNA sequencing-barcoding kit (SQK-PCB109) following the manufacturer\u2019s protocol and sequenced on an R9.4.1 flow cell for 24\u201348 h. Raw reads were converted to TPM values. These data were projected into the SOMs space using the supervised SOMs portrayal (supSOM) approach to predict the SOMs portrait of new samples using support vector machine regression. Results: The CLL transcriptomic landscape reveals disruptions in gene modules (spots) associated with T cell cytotoxicity, B and T cell activation, inflammation, cell cycle, DNA repair, proliferation, and splicing. A specific gene module contained genes associated with poor prognosis in CLL. Accordingly, CLL samples were classified into T-cell cytotoxic, immune, proliferative, splicing, and three mixed types: proliferative\u2013immune, proliferative\u2013splicing, and proliferative\u2013immune\u2013splicing. These transcriptomic subtypes were associated with survival orthogonal to gender and mutation status. Using supervised machine learning approaches, transcriptomic subtypes were assigned to patient samples sequenced with nanopore sequencing. Conclusions: This study demonstrates that the CLL transcriptome landscape can be parsed into functional modules, revealing distinct molecular subtypes based on proliferative and immune activity, with important implications for prognosis and treatment that are orthogonal to other molecular classifications. Additionally, the integration of nanopore sequencing with public datasets and machine learning offers a cost-effective approach to molecular subtyping and prognostic prediction, facilitating more accessible and personalized CLL care.<\/jats:p>","DOI":"10.3390\/cancers17060964","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T10:16:45Z","timestamp":1741861005000},"page":"964","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assigning Transcriptomic Subtypes to Chronic Lymphocytic Leukemia Samples Using Nanopore RNA-Sequencing and Self-Organizing Maps"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6851-1056","authenticated-orcid":false,"given":"Arsen","family":"Arakelyan","sequence":"first","affiliation":[{"name":"Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia"},{"name":"Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan 0051, Armenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Sirunyan","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisane","family":"Khachatryan","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia"},{"name":"Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan 0051, Armenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6875-2482","authenticated-orcid":false,"given":"Siras","family":"Hakobyan","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia"},{"name":"Armenian Bioinformatics Institute, Yerevan 0014, Armenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpine","family":"Minasyan","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Nikoghosyan","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia"},{"name":"Armenian Bioinformatics Institute, Yerevan 0014, Armenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-0655","authenticated-orcid":false,"given":"Meline","family":"Hakobyan","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andranik","family":"Chavushyan","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gevorg","family":"Martirosyan","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology NAS RA, Yerevan 0014, Armenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yervand","family":"Hakobyan","sequence":"additional","affiliation":[{"name":"Hematology Center After Prof. R. Yeolyan MoH RA, Yerevan 0014, Armenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2242-4678","authenticated-orcid":false,"given":"Hans","family":"Binder","sequence":"additional","affiliation":[{"name":"Armenian Bioinformatics Institute, Yerevan 0014, Armenia"},{"name":"Interdisciplinary Center for Bioinformatics, Leipzig University, 04109 Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ajh.25595","article-title":"Chronic Lymphocytic Leukemia: 2020 Update on Diagnosis, Risk Stratification and Treatment","volume":"94","author":"Hallek","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.seminhematol.2024.01.009","article-title":"The Molecular Map of CLL and Richter\u2019s Syndrome","volume":"61","author":"Sud","year":"2024","journal-title":"Semin. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41420-024-02068-2","article-title":"Multiple Omics Levels of Chronic Lymphocytic Leukemia","volume":"10","author":"Turk","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tsagiopoulou, M., and Gut, I.G. (2023). Machine Learning and Multi-Omics Data in Chronic Lymphocytic Leukemia: The Future of Precision Medicine?. Front. Genet., 14.","DOI":"10.3389\/fgene.2023.1304661"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1101\/gr.152132.112","article-title":"Transcriptome Characterization by RNA Sequencing Identifies a Major Molecular and Clinical Subdivision in Chronic Lymphocytic Leukemia","volume":"24","author":"Ferreira","year":"2014","journal-title":"Genome Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Griffen, T.L., Dammer, E.B., Dill, C.D., Carey, K.M., Young, C.D., Nunez, S.K., Ohandjo, A.Q., Kornblau, S.M., and Lillard, J.W. (2021). Multivariate Transcriptome Analysis Identifies Networks and Key Drivers of Chronic Lymphocytic Leukemia Relapse Risk and Patient Survival. BMC Med. Genom., 14.","DOI":"10.1186\/s12920-021-01012-y"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41588-022-01140-w","article-title":"Molecular Map of Chronic Lymphocytic Leukemia and Its Impact on Outcome","volume":"54","author":"Knisbacher","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.humimm.2021.02.006","article-title":"Applications of Next-Generation Sequencing in Hematologic Malignancies","volume":"82","author":"Ramkissoon","year":"2021","journal-title":"Hum. Immunol."},{"key":"ref_9","first-page":"15","article-title":"Limited Resources of Genome Sequencing in Developing Countries: Challenges and Solutions","volume":"9","author":"Helmy","year":"2016","journal-title":"Appl. Transl. Genom."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"MacKenzie, M., and Argyropoulos, C. (2023). An Introduction to Nanopore Sequencing: Past, Present, and Future Considerations. Micromachines, 14.","DOI":"10.20944\/preprints202301.0323.v1"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e2100326","DOI":"10.1200\/PO.21.00326","article-title":"Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA Sequencing","volume":"6","author":"Wang","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1093\/bioinformatics\/btv342","article-title":"oposSOM: R-Package for High-Dimensional Portraying of Genome-Wide Expression Landscapes on Bioconductor","volume":"31","author":"Kalcher","year":"2015","journal-title":"Bioinformatics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting Batch Effects in Microarray Expression Data Using Empirical Bayes Methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wirth, H., L\u00f6ffler, M., von Bergen, M., and Binder, H. (2011). Expression Cartography of Human Tissues Using Self Organizing Maps. BMC Bioinform., 12.","DOI":"10.1186\/1471-2105-12-306"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wirth, H., von Bergen, M., and Binder, H. (2012). Mining SOM Expression Portraits: Feature Selection and Integrating Concepts of Molecular Function. BioData Min., 5.","DOI":"10.1186\/1756-0381-5-18"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"G:Profiler-Interoperable Web Service for Functional Enrichment Analysis and Gene Identifier Mapping (2023 Update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v069.c02","article-title":"Cooccur: Probabilistic Species Co-Occurrence Analysis in R","volume":"69","author":"Griffith","year":"2016","journal-title":"J. Stat. Softw."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13073-019-0637-7","article-title":"A Modular Transcriptome Map of Mature B Cell Lymphomas","volume":"11","author":"Kreuz","year":"2019","journal-title":"Genome Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Arakelyan, A., Melkonyan, A., Hakobyan, S., Boyarskih, U., Simonyan, A., Nersisyan, L., Nikoghosyan, M., Filipenko, M., and Binder, H. (2021). Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031266"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkz114","article-title":"The R Package Rsubread Is Easier, Faster, Cheaper and Better for Alignment and Quantification of RNA Sequencing Reads","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Li, B., and Dewey, C.N. (2011). RSEM: Accurate Transcript Quantification from RNA-Seq Data with or without a Reference Genome. BMC Bioinform., 12.","DOI":"10.1186\/1471-2105-12-323"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/biomedinformatics2010004","article-title":"Projection of High-Dimensional Genome-Wide Expression on SOM Transcriptome Landscapes","volume":"2","author":"Nikoghosyan","year":"2022","journal-title":"BioMedInformatics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(03)15260-9","article-title":"ZAP-70 Expression and Prognosis in Chronic Lymphocytic Leukaemia","volume":"363","author":"Orchard","year":"2004","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1158\/1078-0432.CCR-10-2058","article-title":"A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia","volume":"17","author":"Collins","year":"2011","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3324\/haematol.2012.070201","article-title":"CLLU1 Expression Has Prognostic Value in Chronic Lymphocytic Leukemia after First-Line Therapy in Younger Patients and in Those with Mutated IGHV Genes","volume":"98","author":"Gonzalez","year":"2013","journal-title":"Haematologica"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-0609.2009.01287.x","article-title":"Combined PER2 and CRY1 Expression Predicts Outcome in Chronic Lymphocytic Leukemia","volume":"83","author":"Eisele","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1158\/0008-5472.CAN-07-2707","article-title":"Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function","volume":"68","author":"Massarweh","year":"2008","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.1158\/0008-5472.CAN-08-1404","article-title":"Development of Resistance to Targeted Therapies Transforms the Clinically Associated Molecular Profile Subtype of Breast Tumor Xenografts","volume":"68","author":"Creighton","year":"2008","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3652107","DOI":"10.1155\/2022\/3652107","article-title":"Identification of Six Diagnostic Biomarkers for Chronic Lymphocytic Leukemia Based on Machine Learning Algorithms","volume":"2022","author":"Zhu","year":"2022","journal-title":"J. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3324\/haematol.2018.187583","article-title":"TP53 Aberrations in Chronic Lymphocytic Leukemia: An Overview of the Clinical Implications of Improved Diagnostics","volume":"103","author":"Campo","year":"2018","journal-title":"Haematologica"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.3324\/haematol.2022.281869","article-title":"Subgroup-Specific Gene Expression Profiles and Mixed Epistasis in Chronic Lymphocytic Leukemia","volume":"108","author":"Lu","year":"2023","journal-title":"Haematologica"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vlachonikola, E., Stamatopoulos, K., and Chatzidimitriou, A. (2021). T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.612244"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/s41375-020-0873-2","article-title":"T-Cells in Chronic Lymphocytic Leukemia: Guardians or Drivers of Disease?","volume":"34","author":"Roessner","year":"2020","journal-title":"Leukemia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/leu.2009.145","article-title":"Different Proliferative and Survival Capacity of CLL-Cells in a Newly Established in Vitro Model for Pseudofollicles","volume":"23","author":"Plander","year":"2009","journal-title":"Leukemia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3324\/haematol.2013.101378","article-title":"The Clinical Significance of Patients\u2019 Sex in Chronic Lymphocytic Leukemia","volume":"99","author":"Catovsky","year":"2014","journal-title":"Haematologica"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Schmidt, J., Berghaus, S., Blessing, F., Herbeck, H., Blessing, J., Schierack, P., R\u00f6diger, S., Roggenbuck, D., and Wenzel, F. (2022). Genotyping of Familial Mediterranean Fever Gene (MEFV)-Single Nucleotide Polymorphism-Comparison of Nanopore with Conventional Sanger Sequencing. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0265622"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sun, X., Song, J., Leng, X., Li, F., Wang, H., He, J., Zhai, W., Wang, Z., Wu, Q., and Li, Z. (2023). A Preliminary Evaluation of Targeted Nanopore Sequencing Technology for the Detection of Mycobacterium Tuberculosis in Bronchoalveolar Lavage Fluid Specimens. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1107990"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Avetyan, D., Hakobyan, S., Nikoghosyan, M., Ghukasyan, L., Khachatryan, G., Sirunyan, T., Muradyan, N., Zakharyan, R., Chavushyan, A., and Hayrapetyan, V. (2022). Molecular Analysis of SARS-CoV-2 Lineages in Armenia. Viruses, 14.","DOI":"10.3390\/v14051074"},{"key":"ref_39","first-page":"A68","article-title":"The Cancer Genome Atlas (TCGA): An Immeasurable Source of Knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp. Oncol."},{"key":"ref_40","first-page":"001198","article-title":"The Long and Short of It: Benchmarking Viromics Using Illumina, Nanopore and PacBio Sequencing Technologies","volume":"10","author":"Cook","year":"2024","journal-title":"Microb. Genom."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/6\/964\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:52:46Z","timestamp":1760028766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/6\/964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["cancers17060964"],"URL":"https:\/\/doi.org\/10.3390\/cancers17060964","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]}}}